Home › Inflammatory Bowel Disease
Inflammatory Bowel Disease clinical trials recruiting in the U.S.
72 studies for Inflammatory Bowel Disease are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY18 studies
- Boston, MA15 studies
- Seattle, WA9 studies
- Miami, FL9 studies
- Houston, TX8 studies
- Orlando, FL8 studies
- Atlanta, GA8 studies
- Durham, NC8 studies
- Washington, DC7 studies
- St. Louis, MO7 studies
- Philadelphia, PA7 studies
- Cincinnati, OH7 studies
- Baltimore, MD6 studies
- Mountain View, CA5 studies
- Round Rock, TX5 studies
- Tyler, TX5 studies
- San Diego, CA5 studies
- Ann Arbor, MI5 studies
- Pittsburgh, PA5 studies
- Cleveland, OH5 studies
- Providence, RI5 studies
- Los Angeles, CA5 studies
- Garland, TX4 studies
- Tampa, FL4 studies
- Fort Worth, TX4 studies
- Hartford, CT4 studies
- Milwaukee, WI4 studies
- Parma, OH4 studies
- Colorado Springs, CO4 studies
- Lewisville, TX4 studies
- Chicago, IL4 studies
- Memphis, TN3 studies
- League City, TX3 studies
- San Antonio, TX3 studies
- Louisville, KY3 studies
- Dayton, OH3 studies
- Scottsdale, AZ3 studies
- Richmond, VA3 studies
- Raleigh, NC3 studies
- Kendall, FL3 studies
By state
- Arizona6 studies
- Arkansas3 studies
- California18 studies
- Colorado5 studies
- Connecticut8 studies
- Florida11 studies
- Georgia9 studies
- Illinois7 studies
- Iowa3 studies
- Kansas3 studies
- Kentucky4 studies
- Louisiana6 studies
- Maryland11 studies
- Massachusetts15 studies
- Michigan6 studies
- Minnesota3 studies
- Mississippi3 studies
- Missouri7 studies
- Nevada3 studies
- New Jersey5 studies
- New York21 studies
- North Carolina14 studies
- Ohio16 studies
- Pennsylvania11 studies
- Rhode Island5 studies
- South Carolina4 studies
- Tennessee7 studies
- Texas16 studies
- Utah3 studies
- Virginia6 studies
- Washington10 studies
- Wisconsin4 studies
Recently updated studies
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Oct 2, 2026 · NCT07619547Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RecruitingHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
RecruitingHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07852273A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07845487Immune Regulation in Ulcerative Colitis or Crohn s Disease
RecruitingObservational studyHealthy volunteers welcome
1 Day – 75 Years · All sexes · Updated Sep 28, 2026 · NCT00001184Non-nutritive Sweeteners in Inflammatory Bowel Disease
RecruitingHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 25, 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Study of DISC-0974-201 in Participants With IBD and Anemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07368972A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 22, 2026 · NCT06226883Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT04685200A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RecruitingPhase 3
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 21, 2026 · NCT07513181Observational Pharmaco-Epidemiology Research & Analysis
RecruitingObservational studyHealthy volunteers welcome
Ages 0 and older · All sexes · Updated Sep 11, 2026 · NCT03813862Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
RecruitingObservational study
1 Month – 115 Years · All sexes · Updated Sep 9, 2026 · NCT00001456A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
RecruitingPhase 4
3 Weeks · Women · Updated Sep 8, 2026 · NCT07612267Familial Inflammatory Bowel Disease Early Risk
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 55 · All sexes · Updated Aug 28, 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06274554A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
RecruitingObservational study
Ages 18 to 45 · Women · Updated Aug 11, 2026 · NCT00904878BOOM-IBD2 Pivotal Clinical Trial
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 6, 2026 · NCT07077746From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.